vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and ManpowerGroup Inc. (MAN). Click either name above to swap in a different company.
ManpowerGroup Inc. is the larger business by last-quarter revenue ($4.7B vs $236.8M, roughly 19.9× CROSS COUNTRY HEALTHCARE INC). ManpowerGroup Inc. runs the higher net margin — 0.6% vs -35.0%, a 35.7% gap on every dollar of revenue. On growth, ManpowerGroup Inc. posted the faster year-over-year revenue change (7.1% vs -23.6%). ManpowerGroup Inc. produced more free cash flow last quarter ($168.0M vs $16.1M). Over the past eight quarters, ManpowerGroup Inc.'s revenue compounded faster (3.5% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
ManpowerGroup is an American multinational corporation headquartered in Milwaukee, Wisconsin. Founded in 1948 by Elmer Winter and Aaron Scheinfeld, ManpowerGroup is the third-largest staffing firm in the world behind Swiss firm Adecco and Dutch firm Randstad NV. The company provides administrative & support services, professional services, and business services through its four primary brands: Manpower, Experis, Right Management, and ManpowerGroup Solutions.
CCRN vs MAN — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $4.7B |
| Net Profit | $-82.9M | $30.2M |
| Gross Margin | — | 16.3% |
| Operating Margin | -30.2% | 1.7% |
| Net Margin | -35.0% | 0.6% |
| Revenue YoY | -23.6% | 7.1% |
| Net Profit YoY | -2109.7% | 34.2% |
| EPS (diluted) | $-2.56 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $4.7B | ||
| Q3 25 | $250.1M | $4.6B | ||
| Q2 25 | $274.1M | $4.5B | ||
| Q1 25 | $293.4M | $4.1B | ||
| Q4 24 | $309.9M | $4.4B | ||
| Q3 24 | $315.1M | $4.5B | ||
| Q2 24 | $339.8M | $4.5B | ||
| Q1 24 | $379.2M | $4.4B |
| Q4 25 | $-82.9M | $30.2M | ||
| Q3 25 | $-4.8M | $18.0M | ||
| Q2 25 | $-6.7M | $-67.1M | ||
| Q1 25 | $-490.0K | $5.6M | ||
| Q4 24 | $-3.8M | $22.5M | ||
| Q3 24 | $2.6M | $22.8M | ||
| Q2 24 | $-16.1M | $60.1M | ||
| Q1 24 | $2.7M | $39.7M |
| Q4 25 | — | 16.3% | ||
| Q3 25 | 20.4% | 16.6% | ||
| Q2 25 | 20.4% | 16.9% | ||
| Q1 25 | 20.0% | 17.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | 20.4% | 17.3% | ||
| Q2 24 | 20.8% | 17.4% | ||
| Q1 24 | 20.4% | 17.3% |
| Q4 25 | -30.2% | 1.7% | ||
| Q3 25 | -2.4% | 1.4% | ||
| Q2 25 | -2.1% | -0.6% | ||
| Q1 25 | -0.3% | 0.7% | ||
| Q4 24 | -1.1% | 1.6% | ||
| Q3 24 | 0.9% | 1.6% | ||
| Q2 24 | -5.7% | 2.2% | ||
| Q1 24 | 0.8% | 1.5% |
| Q4 25 | -35.0% | 0.6% | ||
| Q3 25 | -1.9% | 0.4% | ||
| Q2 25 | -2.4% | -1.5% | ||
| Q1 25 | -0.2% | 0.1% | ||
| Q4 24 | -1.2% | 0.5% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | -4.7% | 1.3% | ||
| Q1 24 | 0.7% | 0.9% |
| Q4 25 | $-2.56 | $0.65 | ||
| Q3 25 | $-0.15 | $0.38 | ||
| Q2 25 | $-0.20 | $-1.44 | ||
| Q1 25 | $-0.02 | $0.12 | ||
| Q4 24 | $-0.13 | $0.49 | ||
| Q3 24 | $0.08 | $0.47 | ||
| Q2 24 | $-0.47 | $1.24 | ||
| Q1 24 | $0.08 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $871.0M |
| Total DebtLower is stronger | — | $1.1B |
| Stockholders' EquityBook value | $322.8M | $2.1B |
| Total Assets | $449.0M | $9.2B |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $871.0M | ||
| Q3 25 | $99.1M | $274.6M | ||
| Q2 25 | $81.2M | $289.8M | ||
| Q1 25 | $80.7M | $395.0M | ||
| Q4 24 | $81.6M | $509.4M | ||
| Q3 24 | $64.0M | $410.9M | ||
| Q2 24 | $69.6M | $468.9M | ||
| Q1 24 | $5.2M | $604.8M |
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $468.3M | ||
| Q2 25 | — | $470.3M | ||
| Q1 25 | — | $971.4M | ||
| Q4 24 | — | $929.4M | ||
| Q3 24 | — | $999.7M | ||
| Q2 24 | — | $961.7M | ||
| Q1 24 | — | $968.9M |
| Q4 25 | $322.8M | $2.1B | ||
| Q3 25 | $408.1M | $2.0B | ||
| Q2 25 | $412.2M | $2.0B | ||
| Q1 25 | $418.2M | $2.1B | ||
| Q4 24 | $419.0M | $2.1B | ||
| Q3 24 | $424.7M | $2.2B | ||
| Q2 24 | $433.3M | $2.1B | ||
| Q1 24 | $462.4M | $2.2B |
| Q4 25 | $449.0M | $9.2B | ||
| Q3 25 | $538.2M | $8.4B | ||
| Q2 25 | $553.8M | $8.5B | ||
| Q1 25 | $576.2M | $8.0B | ||
| Q4 24 | $589.3M | $8.2B | ||
| Q3 24 | $597.4M | $8.5B | ||
| Q2 24 | $602.9M | $8.5B | ||
| Q1 24 | $648.4M | $8.5B |
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | 0.46× | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | — | 0.45× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $178.9M |
| Free Cash FlowOCF − Capex | $16.1M | $168.0M |
| FCF MarginFCF / Revenue | 6.8% | 3.6% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 5.92× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $-161.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $178.9M | ||
| Q3 25 | $20.1M | $59.8M | ||
| Q2 25 | $4.2M | $-189.6M | ||
| Q1 25 | $5.7M | $-153.2M | ||
| Q4 24 | $24.2M | $247.6M | ||
| Q3 24 | $7.5M | $83.5M | ||
| Q2 24 | $82.4M | $-137.9M | ||
| Q1 24 | $6.0M | $116.0M |
| Q4 25 | $16.1M | $168.0M | ||
| Q3 25 | $17.9M | $44.7M | ||
| Q2 25 | $2.3M | $-207.2M | ||
| Q1 25 | $3.8M | $-166.9M | ||
| Q4 24 | $21.7M | $236.3M | ||
| Q3 24 | $6.3M | $67.4M | ||
| Q2 24 | $79.6M | $-149.8M | ||
| Q1 24 | $3.8M | $104.2M |
| Q4 25 | 6.8% | 3.6% | ||
| Q3 25 | 7.2% | 1.0% | ||
| Q2 25 | 0.8% | -4.6% | ||
| Q1 25 | 1.3% | -4.1% | ||
| Q4 24 | 7.0% | 5.4% | ||
| Q3 24 | 2.0% | 1.5% | ||
| Q2 24 | 23.4% | -3.3% | ||
| Q1 24 | 1.0% | 2.4% |
| Q4 25 | 0.9% | 0.2% | ||
| Q3 25 | 0.9% | 0.3% | ||
| Q2 25 | 0.7% | 0.4% | ||
| Q1 25 | 0.6% | 0.3% | ||
| Q4 24 | 0.8% | 0.3% | ||
| Q3 24 | 0.4% | 0.4% | ||
| Q2 24 | 0.8% | 0.3% | ||
| Q1 24 | 0.6% | 0.3% |
| Q4 25 | — | 5.92× | ||
| Q3 25 | — | 3.32× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -27.36× | ||
| Q4 24 | — | 11.00× | ||
| Q3 24 | 2.92× | 3.66× | ||
| Q2 24 | — | -2.29× | ||
| Q1 24 | 2.23× | 2.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
MAN
| Other | $2.4B | 52% |
| Transferred Over Time | $1.1B | 24% |
| Staffingand Interim | $1.0B | 22% |
| Productsand Services Other | $50.8M | 1% |
| Permanent Recruitment | $37.5M | 1% |
| Outcome Based Solutionsand Consulting | $20.7M | 0% |
| Transferred At Point In Time | $20.4M | 0% |
